Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy
5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue barriers like stratum corneum (SC) of skin. Here, we aimed to develop 5-ALA loaded ultradeformable liposomes (UDL) with different surface charges,...
Saved in:
Published in | European journal of pharmaceutical sciences Vol. 44; no. 1; pp. 149 - 157 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Kindlington
Elsevier B.V
18.09.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue barriers like stratum corneum (SC) of skin. Here, we aimed to develop 5-ALA loaded ultradeformable liposomes (UDL) with different surface charges, and to investigate their physicochemical characteristics and capability for the skin penetration and retention of 5-ALA for topical photodynamic therapy (PDT). The effects of surface charges of UDL on
in vitro permeation of 5-ALA and
in vivo accumulation of 5-ALA−induced PpIX in viable skin were determined and then compared with conventional neutral liposomes (nLiposome). All UDL showed smaller particle size and better deformability than nLiposome. However, entrapment efficiency of 5-ALA was similar to each vesicle. Among vesicles, the cationic UDL (cUDL) demonstrated higher stability and permeability, and could deliver 5-ALA into deep skin tissue by topical application. Moreover, the 5-ALA loaded in cUDL was long retained, and induced more amount of PpIX in viable skin than those in other UDL and nLiposome. Considering that the conversion of 5-ALA into PpIX occurs preferentially in epidermis, these results suggested that topical delivery of 5-ALA loaded in cUDL could be an interesting proposal to optimize PDT related to 5-ALA. |
---|---|
AbstractList | 5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue barriers like stratum corneum (SC) of skin. Here, we aimed to develop 5-ALA loaded ultradeformable liposomes (UDL) with different surface charges, and to investigate their physicochemical characteristics and capability for the skin penetration and retention of 5-ALA for topical photodynamic therapy (PDT). The effects of surface charges of UDL on in vitro permeation of 5-ALA and in vivo accumulation of 5-ALA-induced PpIX in viable skin were determined and then compared with conventional neutral liposomes (nLiposome). All UDL showed smaller particle size and better deformability than nLiposome. However, entrapment efficiency of 5-ALA was similar to each vesicle. Among vesicles, the cationic UDL (cUDL) demonstrated higher stability and permeability, and could deliver 5-ALA into deep skin tissue by topical application. Moreover, the 5-ALA loaded in cUDL was long retained, and induced more amount of PpIX in viable skin than those in other UDL and nLiposome. Considering that the conversion of 5-ALA into PpIX occurs preferentially in epidermis, these results suggested that topical delivery of 5-ALA loaded in cUDL could be an interesting proposal to optimize PDT related to 5-ALA. 5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue barriers like stratum corneum (SC) of skin. Here, we aimed to develop 5-ALA loaded ultradeformable liposomes (UDL) with different surface charges, and to investigate their physicochemical characteristics and capability for the skin penetration and retention of 5-ALA for topical photodynamic therapy (PDT). The effects of surface charges of UDL on in vitro permeation of 5-ALA and in vivo accumulation of 5-ALA−induced PpIX in viable skin were determined and then compared with conventional neutral liposomes (nLiposome). All UDL showed smaller particle size and better deformability than nLiposome. However, entrapment efficiency of 5-ALA was similar to each vesicle. Among vesicles, the cationic UDL (cUDL) demonstrated higher stability and permeability, and could deliver 5-ALA into deep skin tissue by topical application. Moreover, the 5-ALA loaded in cUDL was long retained, and induced more amount of PpIX in viable skin than those in other UDL and nLiposome. Considering that the conversion of 5-ALA into PpIX occurs preferentially in epidermis, these results suggested that topical delivery of 5-ALA loaded in cUDL could be an interesting proposal to optimize PDT related to 5-ALA. |
Author | Kim, Jin-Ki Kim, Chong-Kook Jin, Su-Eon Park, Jeong-Sook Oh, Eun kyung Park, Youmie |
Author_xml | – sequence: 1 givenname: Eun kyung surname: Oh fullname: Oh, Eun kyung organization: College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea – sequence: 2 givenname: Su-Eon surname: Jin fullname: Jin, Su-Eon organization: College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea – sequence: 3 givenname: Jin-Ki surname: Kim fullname: Kim, Jin-Ki organization: College of Pharmacy, Hanyang University, Ansan Gyeonggi 426-791, Republic of Korea – sequence: 4 givenname: Jeong-Sook surname: Park fullname: Park, Jeong-Sook organization: College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 305-764, Republic of Korea – sequence: 5 givenname: Youmie surname: Park fullname: Park, Youmie organization: College of Pharmacy, Inje University, Gimhae Gyungnam 621-749, Republic of Korea – sequence: 6 givenname: Chong-Kook surname: Kim fullname: Kim, Chong-Kook email: ckkim@inje.ac.kr, ckkim@plaza.snu.ac.kr, ckkim@snu.ac.kr organization: College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24488482$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21782942$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kEGL1DAYhoOsuLOrf8CD5CKeWpNM2iTgRRbdFRYE0XNIk69uhjSpSTow_96WGfXm6YOX5335eG7QVUwREHpNSUsJ7d8fWjjMpWWE0paIlpD9M7SjUqiGCEau0I4oJhuipLhGN6UcCCG9FOQFumZUSKY426H6DarxERyuafbWBOwg-CPkE04j7hoz-ZgCHJfgo7fYWO_wUnz8ia2pPm3ZEmo2DsaUJzMEwMHPqaQJCl4jPD-lmtwprkMW1yfIZj69RM9HEwq8utxb9OPzp-93D83j1_svdx8fG8s7WhvX9dbRfjCcipEpZsGObnBO9gMRe6BuVNbaTlIhpOoN4YpzpQbBe04VQL-_Re_Ou3NOvxYoVU--WAjBREhL0VJyyTuh6EqyM2lzKiXDqOfsJ5NPmhK9ydYHvcnWm2xNhF5lr6U3l_llmMD9rfyxuwJvL4Apq9oxm2h9-cdxvn2wcR_OHKwyjh6yLtZDtOB8Blu1S_5_f_wGknSiEQ |
CitedBy_id | crossref_primary_10_3109_03639045_2016_1165691 crossref_primary_10_3390_ijms22189743 crossref_primary_10_1016_j_jconrel_2017_11_049 crossref_primary_10_1016_j_pdpdt_2017_08_011 crossref_primary_10_1039_D2NA00530A crossref_primary_10_1021_acsami_9b04305 crossref_primary_10_1021_acs_molpharmaceut_7b00099 crossref_primary_10_1016_j_ijpharm_2015_08_036 crossref_primary_10_1002_anbr_202400003 crossref_primary_10_1021_acs_molpharmaceut_3c00494 crossref_primary_10_1080_17425247_2016_1206073 crossref_primary_10_1039_c3py00049d crossref_primary_10_1080_10837450_2021_2004606 crossref_primary_10_1088_0957_4484_24_32_325101 crossref_primary_10_3390_molecules25215184 crossref_primary_10_4155_tde_2016_0093 crossref_primary_10_2174_1381612826666200826140448 crossref_primary_10_1016_j_jddst_2019_101329 crossref_primary_10_1517_17425247_2012_697894 crossref_primary_10_3390_pharmaceutics13010033 crossref_primary_10_1016_j_ajps_2013_07_016 crossref_primary_10_2174_1574885513666181112153213 crossref_primary_10_1080_10717544_2022_2108939 crossref_primary_10_2217_nnm_2021_0335 crossref_primary_10_3390_ph14080772 crossref_primary_10_1002_smll_201502131 crossref_primary_10_1016_j_colsurfb_2019_03_021 crossref_primary_10_2174_1389450122999210101230743 crossref_primary_10_1016_j_ejps_2015_12_003 crossref_primary_10_1186_s12951_023_01877_4 crossref_primary_10_1155_2014_895986 crossref_primary_10_1021_acsanm_2c01805 crossref_primary_10_1007_s00432_023_05429_z crossref_primary_10_1016_j_xphs_2023_10_033 crossref_primary_10_1517_17425247_2013_779252 crossref_primary_10_1016_j_jddst_2015_04_009 crossref_primary_10_4155_tde_2017_0075 crossref_primary_10_1016_j_jddst_2022_103933 crossref_primary_10_53879_id_58_11_12216 crossref_primary_10_1016_j_drudis_2013_04_003 crossref_primary_10_1039_C5RA26737D crossref_primary_10_1080_17425247_2024_2318460 crossref_primary_10_1371_journal_pone_0148850 crossref_primary_10_1016_j_neo_2022_100810 crossref_primary_10_1021_acsnano_8b03007 crossref_primary_10_1016_j_plipres_2016_08_005 crossref_primary_10_2174_0929867325666181116143713 crossref_primary_10_1016_j_jddst_2019_01_028 |
Cites_doi | 10.1080/03639040500216170 10.1016/j.bbamem.2004.01.006 10.1081/DDC-120025458 10.1016/j.jconrel.2004.08.025 10.3109/10611860108995632 10.1016/j.ejpb.2005.01.011 10.3109/02652048.2010.507880 10.1016/S0142-9612(03)00534-9 10.1002/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O 10.1002/ijc.10802 10.1002/jgm.1268 10.1016/j.ijpharm.2010.06.034 10.1038/sj.bjc.6600144 10.1159/000018006 10.1186/1471-5945-1-5 10.1006/abio.2001.5338 10.1562/2004-08-23-IR-283R1.1 10.1016/j.biomaterials.2005.05.097 10.1016/j.ijpharm.2003.10.031 10.1016/S0378-5173(01)00832-8 10.1007/s11095-005-9261-x 10.1016/j.ejpb.2010.01.008 10.1016/j.jconrel.2008.10.003 10.1023/A:1007612905378 10.1016/S0928-0987(01)00167-1 10.1016/j.biomaterials.2004.02.020 10.1046/j.1365-2230.2002.01024.x 10.1038/sj.bjc.6690255 10.1016/j.jphotobiol.2010.06.012 10.1021/js980018w 10.1016/S0005-2736(02)00401-7 |
ContentType | Journal Article |
Copyright | 2011 Elsevier B.V. 2015 INIST-CNRS Copyright © 2011 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2011 Elsevier B.V. – notice: 2015 INIST-CNRS – notice: Copyright © 2011 Elsevier B.V. All rights reserved. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.ejps.2011.07.003 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1879-0720 |
EndPage | 157 |
ExternalDocumentID | 10_1016_j_ejps_2011_07_003 21782942 24488482 S0928098711002260 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 0SF 1B1 1RT 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO ABFNM ABFRF ABJNI ABLJU ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HMT HVGLF HZ~ IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OK1 OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSP SSZ T5K TEORI WUQ ~G- ABPIF ABPTK IQODW AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX ADVLN CITATION 7X8 |
ID | FETCH-LOGICAL-c451t-d56cd16ba417f292cecfdbdd86b073e1df9ccc58177896a0494499b746419ee63 |
IEDL.DBID | .~1 |
ISSN | 0928-0987 |
IngestDate | Fri Oct 25 04:30:11 EDT 2024 Thu Sep 26 17:25:13 EDT 2024 Sat Sep 28 07:48:26 EDT 2024 Sun Oct 22 16:08:58 EDT 2023 Fri Feb 23 02:19:33 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | 5-Aminolevulinic acid Ultradeformable liposome Photodynamic therapy Topical delivery Local administration Pharmaceutical technology Treatment Cationic liposome Topical administration |
Language | English |
License | CC BY 4.0 Copyright © 2011 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c451t-d56cd16ba417f292cecfdbdd86b073e1df9ccc58177896a0494499b746419ee63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21782942 |
PQID | 884845791 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_884845791 crossref_primary_10_1016_j_ejps_2011_07_003 pubmed_primary_21782942 pascalfrancis_primary_24488482 elsevier_sciencedirect_doi_10_1016_j_ejps_2011_07_003 |
PublicationCentury | 2000 |
PublicationDate | 2011-09-18 |
PublicationDateYYYYMMDD | 2011-09-18 |
PublicationDate_xml | – month: 09 year: 2011 text: 2011-09-18 day: 18 |
PublicationDecade | 2010 |
PublicationPlace | Kindlington |
PublicationPlace_xml | – name: Kindlington – name: Netherlands |
PublicationTitle | European journal of pharmaceutical sciences |
PublicationTitleAlternate | Eur J Pharm Sci |
PublicationYear | 2011 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Ogiso, Yamaguchi, Iwaki, Tanino, Miyake (b0115) 2001; 9 Kosobe, Moriyama, Tokuoka (b0085) 2005; 31 Cevc, Blume (b0030) 2004; 1663 Song, Kim (b0145) 2006; 27 De Rosa, Bentley (b0040) 2000; 17 Fritsch, Lehmann, Stahl, Schulte, Blohm, Lang, Sies, Ruzicka (b0055) 1999; 79 Merclin, Bender, Sparr, Guy, Ehrsson, Engstrom (b0100) 2004; 100 Cevc, Schatzlein, Richardsen (b0025) 2002; 1564 Pease, White, Basketter (b0120) 2002; 27 Pierre, Tedesco, Marchetti, Bentley (b0130) 2001; 1 Manosroi, Kongkaneramit, Manosroi (b0095) 2004; 270 Hurlimann, Hanggi, Panizzon (b0065) 1998; 197 Kim, Lee, Choi, Kim (b0075) 2004; 25 Peng, Warloe, Berg, Moan, Kongshaug, Giercksky, Nesland (b0125) 1997; 79 De Campos Araújo, Thomazine, Lopez (b0035) 2010; 75 Casas, Perotti, Saccoliti, Sacca, Fukuda, Batlle (b0020) 2002; 86 Donnelly, McCarron, Woolfson (b0045) 2005; 81 Morrow, McCarron, Woolfson, Juzenas, Juzeniene, Iani, Moan, Donnelly (b0110) 2010; 101 Jain, Jain, Umamaheshwari, Jain (b0070) 2003; 29 Sznitowska, Janicki, Williams (b0155) 1998; 87 Lee, Kim, Oh, Kim (b0090) 2005; 26 Pierre, Ricci, Tedesco, Bentley (b0135) 2006; 23 Barry (b0010) 2001; 14 Betz, Nowbakht, Imboden, Imanidis (b0015) 2001; 228 Moan, MA, Juzeniene, Iani, Juzenas, Apricena, Peng (b0105) 2003; 103 Steluti, De Rosa, Collett, Tedesco, Bentley (b0150) 2005; 60 Song, Hyun, Kim, Kim, Oh (b0140) 2011; 28 Kim, Lee, Park, Jin, Ahn, Kim (b0080) 2009; 11 Geusens, Lambert, De Smedt, Buyens, Sanders, Van Gele (b0060) 2009; 133 Bantan-Polak, Kassai, Grant (b0005) 2001; 297 El Zaafarany, Awadm, Holayel, Mortada (b0050) 2010; 397 Barry (10.1016/j.ejps.2011.07.003_b0010) 2001; 14 Geusens (10.1016/j.ejps.2011.07.003_b0060) 2009; 133 Manosroi (10.1016/j.ejps.2011.07.003_b0095) 2004; 270 Ogiso (10.1016/j.ejps.2011.07.003_b0115) 2001; 9 Pease (10.1016/j.ejps.2011.07.003_b0120) 2002; 27 El Zaafarany (10.1016/j.ejps.2011.07.003_b0050) 2010; 397 Peng (10.1016/j.ejps.2011.07.003_b0125) 1997; 79 Cevc (10.1016/j.ejps.2011.07.003_b0030) 2004; 1663 Jain (10.1016/j.ejps.2011.07.003_b0070) 2003; 29 Kosobe (10.1016/j.ejps.2011.07.003_b0085) 2005; 31 Song (10.1016/j.ejps.2011.07.003_b0140) 2011; 28 Morrow (10.1016/j.ejps.2011.07.003_b0110) 2010; 101 Steluti (10.1016/j.ejps.2011.07.003_b0150) 2005; 60 De Rosa (10.1016/j.ejps.2011.07.003_b0040) 2000; 17 Song (10.1016/j.ejps.2011.07.003_b0145) 2006; 27 Cevc (10.1016/j.ejps.2011.07.003_b0025) 2002; 1564 Moan (10.1016/j.ejps.2011.07.003_b0105) 2003; 103 Sznitowska (10.1016/j.ejps.2011.07.003_b0155) 1998; 87 Betz (10.1016/j.ejps.2011.07.003_b0015) 2001; 228 Pierre (10.1016/j.ejps.2011.07.003_b0130) 2001; 1 Kim (10.1016/j.ejps.2011.07.003_b0080) 2009; 11 De Campos Araújo (10.1016/j.ejps.2011.07.003_b0035) 2010; 75 Hurlimann (10.1016/j.ejps.2011.07.003_b0065) 1998; 197 Kim (10.1016/j.ejps.2011.07.003_b0075) 2004; 25 Casas (10.1016/j.ejps.2011.07.003_b0020) 2002; 86 Pierre (10.1016/j.ejps.2011.07.003_b0135) 2006; 23 Fritsch (10.1016/j.ejps.2011.07.003_b0055) 1999; 79 Merclin (10.1016/j.ejps.2011.07.003_b0100) 2004; 100 Bantan-Polak (10.1016/j.ejps.2011.07.003_b0005) 2001; 297 Donnelly (10.1016/j.ejps.2011.07.003_b0045) 2005; 81 Lee (10.1016/j.ejps.2011.07.003_b0090) 2005; 26 |
References_xml | – volume: 103 start-page: 132 year: 2003 end-page: 135 ident: b0105 article-title: Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters publication-title: Int. J. Cancer contributor: fullname: Peng – volume: 297 start-page: 128 year: 2001 end-page: 136 ident: b0005 article-title: A comparison of fluorescamine and naphthalene-2,3-dicarboxaldehyde fluorogenic reagents for microplate-based detection of amino acids publication-title: Anal. Biochem. contributor: fullname: Grant – volume: 31 start-page: 623 year: 2005 end-page: 629 ident: b0085 article-title: Size and surface charge effect of 5-aminolevulinic acid-containing liposomes on photodynamic therapy for cultivated cancer cells publication-title: Drug Dev. Ind. Pharm. contributor: fullname: Tokuoka – volume: 100 start-page: 191 year: 2004 end-page: 198 ident: b0100 article-title: Transdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester publication-title: J. Control. Release contributor: fullname: Engstrom – volume: 26 start-page: 205 year: 2005 end-page: 210 ident: b0090 article-title: Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes publication-title: Biomaterials contributor: fullname: Kim – volume: 11 start-page: 26 year: 2009 end-page: 37 ident: b0080 article-title: Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis publication-title: J. Gene Med. contributor: fullname: Kim – volume: 14 start-page: 101 year: 2001 end-page: 114 ident: b0010 article-title: Novel mechanisms and devices to enable successful transdermal drug delivery publication-title: Eur. J. Pharm. Sci. contributor: fullname: Barry – volume: 17 start-page: 1447 year: 2000 end-page: 1455 ident: b0040 article-title: Photodynamic therapy of skin cancers: sensitizers, clinical studies and future publication-title: Pharm. Res. contributor: fullname: Bentley – volume: 270 start-page: 279 year: 2004 end-page: 286 ident: b0095 article-title: Stability and transdermal absorption of topical amphotericin B liposome formulations publication-title: Int. J. Pharm. contributor: fullname: Manosroi – volume: 28 start-page: 151 year: 2011 end-page: 158 ident: b0140 article-title: Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes publication-title: J. Microencap. contributor: fullname: Oh – volume: 197 start-page: 248 year: 1998 end-page: 254 ident: b0065 article-title: Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion publication-title: Dermatology contributor: fullname: Panizzon – volume: 228 start-page: 147 year: 2001 end-page: 159 ident: b0015 article-title: Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro publication-title: Int. J. Pharm. contributor: fullname: Imanidis – volume: 75 start-page: 48 year: 2010 end-page: 55 ident: b0035 article-title: Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Lopez – volume: 1564 start-page: 21 year: 2002 end-page: 30 ident: b0025 article-title: Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurement publication-title: Biochim Biophy Acta contributor: fullname: Richardsen – volume: 23 start-page: 360 year: 2006 end-page: 366 ident: b0135 article-title: Oleic acid as Optimizer of the skin delivery of 5-aminolevulinic acid photodynamic therapy publication-title: Pharm. Res. contributor: fullname: Bentley – volume: 29 start-page: 1013 year: 2003 end-page: 1026 ident: b0070 article-title: Transfersomes–a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation publication-title: Drug Dev. Ind. Pharm. contributor: fullname: Jain – volume: 1 start-page: 5 year: 2001 ident: b0130 article-title: Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study publication-title: BMC Dermatol. contributor: fullname: Bentley – volume: 1663 start-page: 61 year: 2004 end-page: 73 ident: b0030 article-title: Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage publication-title: Biochim. Biophys. Acta contributor: fullname: Blume – volume: 60 start-page: 439 year: 2005 end-page: 444 ident: b0150 article-title: Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Bentley – volume: 27 start-page: 296 year: 2002 end-page: 300 ident: b0120 article-title: Skin as a route of exposure to protein allergens publication-title: Clin. Exp. Dermatol. contributor: fullname: Basketter – volume: 25 start-page: 305 year: 2004 end-page: 313 ident: b0075 article-title: In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome publication-title: Biomaterials contributor: fullname: Kim – volume: 27 start-page: 271 year: 2006 end-page: 280 ident: b0145 article-title: Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes publication-title: Biomaterials contributor: fullname: Kim – volume: 81 start-page: 750 year: 2005 end-page: 767 ident: b0045 article-title: Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy publication-title: Photochem. Photobiol. contributor: fullname: Woolfson – volume: 133 start-page: 214 year: 2009 end-page: 220 ident: b0060 article-title: Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes publication-title: J. Control. Release contributor: fullname: Van Gele – volume: 101 start-page: 59 year: 2010 end-page: 69 ident: b0110 article-title: Novel patch-based systems for the localized delivery of ALA-esters publication-title: J. Photochem. Photobiol. B contributor: fullname: Donnelly – volume: 9 start-page: 49 year: 2001 end-page: 59 ident: b0115 article-title: Effect of positively and negatively charged liposomes on skin permeation of drugs publication-title: J. Drug Target. contributor: fullname: Miyake – volume: 397 start-page: 164 year: 2010 end-page: 172 ident: b0050 article-title: Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery publication-title: Int. J. Pharm. contributor: fullname: Mortada – volume: 86 start-page: 837 year: 2002 end-page: 842 ident: b0020 article-title: ALA and ALA hexyl ester in free and liposomal formulations for the photosensitization of tumour organ cultures publication-title: Br. J. Cancer contributor: fullname: Batlle – volume: 79 start-page: 1603 year: 1999 end-page: 1608 ident: b0055 article-title: Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid publication-title: Br. J. Cancer contributor: fullname: Ruzicka – volume: 87 start-page: 1109 year: 1998 end-page: 1113 ident: b0155 article-title: Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum publication-title: J. Pharm. Sci. contributor: fullname: Williams – volume: 79 start-page: 2282 year: 1997 end-page: 2308 ident: b0125 article-title: 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges publication-title: Cancer contributor: fullname: Nesland – volume: 31 start-page: 623 year: 2005 ident: 10.1016/j.ejps.2011.07.003_b0085 article-title: Size and surface charge effect of 5-aminolevulinic acid-containing liposomes on photodynamic therapy for cultivated cancer cells publication-title: Drug Dev. Ind. Pharm. doi: 10.1080/03639040500216170 contributor: fullname: Kosobe – volume: 1663 start-page: 61 year: 2004 ident: 10.1016/j.ejps.2011.07.003_b0030 article-title: Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbamem.2004.01.006 contributor: fullname: Cevc – volume: 29 start-page: 1013 year: 2003 ident: 10.1016/j.ejps.2011.07.003_b0070 article-title: Transfersomes–a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation publication-title: Drug Dev. Ind. Pharm. doi: 10.1081/DDC-120025458 contributor: fullname: Jain – volume: 100 start-page: 191 year: 2004 ident: 10.1016/j.ejps.2011.07.003_b0100 article-title: Transdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester publication-title: J. Control. Release doi: 10.1016/j.jconrel.2004.08.025 contributor: fullname: Merclin – volume: 9 start-page: 49 year: 2001 ident: 10.1016/j.ejps.2011.07.003_b0115 article-title: Effect of positively and negatively charged liposomes on skin permeation of drugs publication-title: J. Drug Target. doi: 10.3109/10611860108995632 contributor: fullname: Ogiso – volume: 60 start-page: 439 year: 2005 ident: 10.1016/j.ejps.2011.07.003_b0150 article-title: Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2005.01.011 contributor: fullname: Steluti – volume: 28 start-page: 151 year: 2011 ident: 10.1016/j.ejps.2011.07.003_b0140 article-title: Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes publication-title: J. Microencap. doi: 10.3109/02652048.2010.507880 contributor: fullname: Song – volume: 25 start-page: 305 year: 2004 ident: 10.1016/j.ejps.2011.07.003_b0075 article-title: In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome publication-title: Biomaterials doi: 10.1016/S0142-9612(03)00534-9 contributor: fullname: Kim – volume: 79 start-page: 2282 year: 1997 ident: 10.1016/j.ejps.2011.07.003_b0125 article-title: 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O contributor: fullname: Peng – volume: 103 start-page: 132 year: 2003 ident: 10.1016/j.ejps.2011.07.003_b0105 article-title: Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters publication-title: Int. J. Cancer doi: 10.1002/ijc.10802 contributor: fullname: Moan – volume: 11 start-page: 26 year: 2009 ident: 10.1016/j.ejps.2011.07.003_b0080 article-title: Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis publication-title: J. Gene Med. doi: 10.1002/jgm.1268 contributor: fullname: Kim – volume: 397 start-page: 164 year: 2010 ident: 10.1016/j.ejps.2011.07.003_b0050 article-title: Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2010.06.034 contributor: fullname: El Zaafarany – volume: 86 start-page: 837 year: 2002 ident: 10.1016/j.ejps.2011.07.003_b0020 article-title: ALA and ALA hexyl ester in free and liposomal formulations for the photosensitization of tumour organ cultures publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6600144 contributor: fullname: Casas – volume: 197 start-page: 248 year: 1998 ident: 10.1016/j.ejps.2011.07.003_b0065 article-title: Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion publication-title: Dermatology doi: 10.1159/000018006 contributor: fullname: Hurlimann – volume: 1 start-page: 5 year: 2001 ident: 10.1016/j.ejps.2011.07.003_b0130 article-title: Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study publication-title: BMC Dermatol. doi: 10.1186/1471-5945-1-5 contributor: fullname: Pierre – volume: 297 start-page: 128 year: 2001 ident: 10.1016/j.ejps.2011.07.003_b0005 article-title: A comparison of fluorescamine and naphthalene-2,3-dicarboxaldehyde fluorogenic reagents for microplate-based detection of amino acids publication-title: Anal. Biochem. doi: 10.1006/abio.2001.5338 contributor: fullname: Bantan-Polak – volume: 81 start-page: 750 year: 2005 ident: 10.1016/j.ejps.2011.07.003_b0045 article-title: Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy publication-title: Photochem. Photobiol. doi: 10.1562/2004-08-23-IR-283R1.1 contributor: fullname: Donnelly – volume: 27 start-page: 271 year: 2006 ident: 10.1016/j.ejps.2011.07.003_b0145 article-title: Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes publication-title: Biomaterials doi: 10.1016/j.biomaterials.2005.05.097 contributor: fullname: Song – volume: 270 start-page: 279 year: 2004 ident: 10.1016/j.ejps.2011.07.003_b0095 article-title: Stability and transdermal absorption of topical amphotericin B liposome formulations publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2003.10.031 contributor: fullname: Manosroi – volume: 228 start-page: 147 year: 2001 ident: 10.1016/j.ejps.2011.07.003_b0015 article-title: Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(01)00832-8 contributor: fullname: Betz – volume: 23 start-page: 360 year: 2006 ident: 10.1016/j.ejps.2011.07.003_b0135 article-title: Oleic acid as Optimizer of the skin delivery of 5-aminolevulinic acid photodynamic therapy publication-title: Pharm. Res. doi: 10.1007/s11095-005-9261-x contributor: fullname: Pierre – volume: 75 start-page: 48 year: 2010 ident: 10.1016/j.ejps.2011.07.003_b0035 article-title: Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2010.01.008 contributor: fullname: De Campos Araújo – volume: 133 start-page: 214 year: 2009 ident: 10.1016/j.ejps.2011.07.003_b0060 article-title: Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes publication-title: J. Control. Release doi: 10.1016/j.jconrel.2008.10.003 contributor: fullname: Geusens – volume: 17 start-page: 1447 year: 2000 ident: 10.1016/j.ejps.2011.07.003_b0040 article-title: Photodynamic therapy of skin cancers: sensitizers, clinical studies and future publication-title: Pharm. Res. doi: 10.1023/A:1007612905378 contributor: fullname: De Rosa – volume: 14 start-page: 101 year: 2001 ident: 10.1016/j.ejps.2011.07.003_b0010 article-title: Novel mechanisms and devices to enable successful transdermal drug delivery publication-title: Eur. J. Pharm. Sci. doi: 10.1016/S0928-0987(01)00167-1 contributor: fullname: Barry – volume: 26 start-page: 205 year: 2005 ident: 10.1016/j.ejps.2011.07.003_b0090 article-title: Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes publication-title: Biomaterials doi: 10.1016/j.biomaterials.2004.02.020 contributor: fullname: Lee – volume: 27 start-page: 296 year: 2002 ident: 10.1016/j.ejps.2011.07.003_b0120 article-title: Skin as a route of exposure to protein allergens publication-title: Clin. Exp. Dermatol. doi: 10.1046/j.1365-2230.2002.01024.x contributor: fullname: Pease – volume: 79 start-page: 1603 year: 1999 ident: 10.1016/j.ejps.2011.07.003_b0055 article-title: Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6690255 contributor: fullname: Fritsch – volume: 101 start-page: 59 year: 2010 ident: 10.1016/j.ejps.2011.07.003_b0110 article-title: Novel patch-based systems for the localized delivery of ALA-esters publication-title: J. Photochem. Photobiol. B doi: 10.1016/j.jphotobiol.2010.06.012 contributor: fullname: Morrow – volume: 87 start-page: 1109 year: 1998 ident: 10.1016/j.ejps.2011.07.003_b0155 article-title: Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum publication-title: J. Pharm. Sci. doi: 10.1021/js980018w contributor: fullname: Sznitowska – volume: 1564 start-page: 21 year: 2002 ident: 10.1016/j.ejps.2011.07.003_b0025 article-title: Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurement publication-title: Biochim Biophy Acta doi: 10.1016/S0005-2736(02)00401-7 contributor: fullname: Cevc |
SSID | ssj0006870 |
Score | 2.2967887 |
Snippet | 5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 149 |
SubjectTerms | 5-Aminolevulinic acid Administration, Topical Aminolevulinic Acid - administration & dosage Aminolevulinic Acid - pharmacokinetics Aminolevulinic Acid - therapeutic use Animals Biological and medical sciences Cations Drug Compounding Drug Stability General pharmacology In Vitro Techniques Liposomes Male Medical sciences Mice Mice, Hairless Particle Size Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Photochemotherapy - methods Photodynamic therapy Photosensitizing Agents - administration & dosage Photosensitizing Agents - pharmacokinetics Photosensitizing Agents - therapeutic use Protoporphyrins - biosynthesis Skin - metabolism Skin Absorption Skin Diseases - drug therapy Skin Diseases - metabolism Surface Properties Topical delivery Ultradeformable liposome |
Title | Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy |
URI | https://dx.doi.org/10.1016/j.ejps.2011.07.003 https://www.ncbi.nlm.nih.gov/pubmed/21782942 https://search.proquest.com/docview/884845791 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqckFCiDfLY-UD6oWGzcN27GNVUS0gqgpaqbfIsR1IlcZRk0XaC7-dmThh1UM5cHXsJPJnz8Oeb4aQdwCxzEDPRSbNHZYwE5GuBGz3NGNxBfpZj-cdX0_F-oJ9vuSXe-R45sJgWOUk-4NMH6X11LKaZnPV1fXqe6xSGYPLjEnPwIhAv52B-oM1_eH3LsxDyLFgHHaOsPdEnAkxXu6q66c0npjJMLtLOT3odA9TVoVaF3cbo6NSOnlEHk7WJD0KP_yY7Ln2CTk4C-mot4f0fMeu6g_pAT3bJarePiXDN4wfBTlLB98hWNS6BuM0ttRXlEf6um59435tRvYk1aa2FOPkf9Bwzgdtm2a40daNlm_ZONrUne_9tespNNHupx-8DTXvaWB6bZ-Ri5OP58fraKrCEBnGkyGyXBibiFKzJK9SlRpnKltaK0UJ4sEltlLGGC6TPJdKaMw3A15UmTPBEuWcyJ6T_da37iXywzOQGYYroTLGS_DjY24c0o1ieGvGF-T9PP1FF5JtFHMU2lWBYBUIVhHjnXm2IHxGqLi1ZArQBv8ct7wF599PgaUjJZPpgtAZ3wI2G96g6Nb5TV_gY8ZzlSzIi4D7bnACtpZi6av__KvX5H44rlZRIt-Q_eFm496CvTOUy3FBL8m9o09f1qd_ABpkAWI |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQHFqpquh7S0t9qLiUaPOwHfuIUNFSYIXaReJmJbZDg0IckSzS_nvGccKKAxy4OnFi-bNnvrHngdBPgJgnoOcCFafGlTBjQVYw2O5xQsIC9HPWn3eczdnsgvy5pJcb6HCMhXFulYPs9zK9l9ZDy3SYzWlTltN_oYh5CCazS3oGJALs9i1gAwJ259bB8cls_iCQGe9rxrn3A9dhiJ3xbl7mummHTJ4umWHylH5602QtzFrhy108zUd7vXS0jd4OhBIf-DG_Qxumfo_2zn1G6tU-XqwDrNp9vIfP17mqVx9Q99e5kIKoxZ1tHF5Ym8q5aqywLTANspuytpW5W_YBlDhTpcbOVf4K-6M-aFtW3W2mTU9-88rgqmxsa29Mi6EJN_9tZ7Uve499sNfqI7o4-r04nAVDIYZAERp1gaZM6YjlGYnSIhaxMqrQudac5SAhTKQLoZSiPEpTLljmUs6AIZWnhJFIGMOST2iztrX54kLEExAbigomEkJzMOVDqoyLOArhqwmdoF_j9MvG59uQoyPatXRgSQeWDN21eTJBdERIPlo1EhTCs_12H8H58CsgO5wTHk8QHvGVsN_cJUpWG7tspXtMaCqiCfrscV93joBuCRJ_feGofqBXs8XZqTw9np_soNf-9FoEEf-GNrvbpfkO9KfLd4flfQ_m4AQW |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retained+topical+delivery+of+5-aminolevulinic+acid+using+cationic+ultradeformable+liposomes+for+photodynamic+therapy&rft.jtitle=European+journal+of+pharmaceutical+sciences&rft.au=Oh%2C+Eun+Kyung&rft.au=Jin%2C+Su-Eon&rft.au=Kim%2C+Jin-Ki&rft.au=Park%2C+Jeong-Sook&rft.date=2011-09-18&rft.eissn=1879-0720&rft.volume=44&rft.issue=1-2&rft.spage=149&rft.epage=157&rft_id=info:doi/10.1016%2Fj.ejps.2011.07.003&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0928-0987&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0928-0987&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0928-0987&client=summon |